Comparison of the effect of portulaca oleracea L. and foeniculum vulgare mill and vitex agnus castus L. with spironolactone and cyproterone compound on hirsutism on patient with polycystic ovary syndrome
Phase 2
Recruiting
- Conditions
- Polycystic ovarian syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT2016062121653N7
- Lead Sponsor
- Vice chancellor for research ,Jahrom University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 128
Inclusion Criteria
inclusion criteria :oral and written judgment for participation in the study; in the age range of 18 to 40 years of age ; absence of chronic physical illness (other than polycystic ovary syndrome), and mental illness or drug use In the long time, it has been the patient's own words.
Exclusion criteria : history of specific drug use (effects on levels of hormones, blood glucose, insulin or hirsutism); previous history of diabetes, cardiovascular disease, thyroid disease ; other surgical and internal diseases. They do not have PCOS cryptography.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hirsutism. Timepoint: 3 month. Method of measurement: Ferriman-Gallway Scoring system.
- Secondary Outcome Measures
Name Time Method Free testosterone. Timepoint: 3month. Method of measurement: mg/ml.;Follicle-stimulating hormone. Timepoint: 3 month. Method of measurement: mg/ml.;Luteinizing Hormone. Timepoint: 3 month. Method of measurement: mg/ml.